This country profile provides an overview of Malawi’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
100%
Blinding trachoma
90%
Intestinal worms
82%
Bilharzia
100%
River blindness
86%
7.76 million people received treatment in Malawi in 2017 4.01 million people did not receive treatment in Malawi in 2017

Priorities for progress in Malawi

  • Malawi has a well implemented and consistent preventive chemotherapy programme for NTDs.
  • Malawi is encouraged to work to maintain the annual implementation of all components, in all risk groups, as an example for the African region.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Malawi is conducting post-preventive chemotherapy surveillance.

Blinding trachoma

Treatment coverage increased from 79% in 2016 to 90% in 2017.

People needing treatment
1.36m
People receiving treatment
1.22m

Intestinal worms

Treatment coverage decreased from 88% in 2016 to 82% in 2017.

Pre-sch and school-aged children needing treatment
7.55m
Pre-school and school-aged children receiving treatment
6.16m

Bilharzia

Treatment coverage increased from 96% in 2016 to 100% in 2017.

School-aged children needing treatment
3.38m
School-aged children receiving treatment
3.38m

River blindness

Treatment coverage remained increased 83% in 2016 to 86% in 2017.

People needing treatment
2.28m
People receiving treatment
1.96m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Malawi.